Peter David Suzdak

Peter David Suzdak founded Cardioxyl Pharmaceuticals LLC in 2006, where he worked as President & Chief Executive Officer.
Dr. Suzdak also founded Artesian Therapeutics, Inc., where he worked as President & Chief Executive Officer.
Dr. Suzdak also currently works at Acidophil LLC, as Director.
Dr. Suzdak also formerly worked at Rexahn Pharmaceuticals, Inc., as Chief Executive Officer & Director from 2013 to 2018, Incara Pharmaceuticals Corp., as Director, Novo Nordisk A, as Director-Neurobiology Research in 1995, Aeolus Pharmaceuticals, Inc., as Independent Director from 2011 to 2013, Guilford Pharmaceuticals, Inc., as Senior Vice President-Research & Development in 2002, National Institute of Mental Health, as Associate-Pharmacology Research in 1988, and Corridor Pharmaceuticals, Inc., as Chief Scientific Officer.
Dr. Suzdak received his undergraduate degree from St. John's University and doctorate degree from the University of Connecticut.